MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Bradykinesia"

  • MDS Virtual Congress 2021

    Prasinezumab reduced progression of Parkinson’s disease motor features measured by Roche PD Mobile Application v2 sensor features: PASADENA Phase II Part 1

    K. Taylor, F. Lipsmeier, E. Volkova-Volkmar, D. Rukina, J. Anzures Cabrera, L. Essioux, M. Abt, B. van Lier, A. Thomann, H. Svoboda, W. Zago, R. Postuma, G. Pagano, M. Lindemann (Basel, Switzerland)

    Objective: To determine whether digital biomarker sensor data detect slowing in progression of core motor features of Parkinson’s disease (PD) in individuals with early PD…
  • MDS Virtual Congress 2021

    Early-onset vs. Late-onset Parkinson’s disease

    H. Slimène, N. Farhat, S. Sakka, O. Hdiji, M. Dammak, C. Mhiri (Sousse, Tunisia)

    Objective: To determine the clinical and therapeutic peculiarities that distinguish Early onset Parkinson’s disease (EOPD) from late onset Parkinson’s disease (LOPD). Background: Age is the…
  • MDS Virtual Congress 2021

    “Striatal Hand Signs” and early diagnosis of Parkinson’s Disease: The “Monkey-Wrench Sign”.

    I. Teixeira, V. Souza, C. Zorzenon, B. Veiga, V. Borges, H. Ferraz (São Paulo, Brazil)

    Objective: To identify signs of hand deformations in PD patients with earlier diseases, and compare with intermediate and late phases patients. Background: “Striatal hand signs”,…
  • MDS Virtual Congress 2021

    Parkinson’s-disease risk variants are differentially associated with discrete phenotypic characteristics of Parkinson’s-disease at baseline.

    B. Chase, A. Premkumar, B. Schoneburg, N. Kartha, J. Wei, H. Yu, A. Epshteyn, L. Garduno, A. Pham, R. Vazquez, R. Frigerio, D. Maraganore, K. Markopoulou (Skokie, USA)

    Objective: Evaluate whether genetic risk variants for Parkinson’s disease discovered in case-control GWAS uniformly or differentially contribute to the clinical phenotype of PD. Background: Genetic…
  • MDS Virtual Congress 2021

    Motor Function Test Protocol for Parkinsonian Triad in Rodent Model of Parkinson’s Disease

    M. Sirajo, K. Murtala, J. Oyem, O. Ishola, O. Lukman (Kano, Nigeria)

    Objective: To review motor deficits protocols and create a set of behavioural protocols that critically address the parkinsonian triad's quantification in Parkinson's disease models. Background:…
  • MDS Virtual Congress 2021

    Longitudinal Speech Changes In PD and the Relationship to Limb Bradykinesia and Rigidity

    R. Richter, S. Gutierrez, R. Bennett, C. Deckelman, F. Docters, A. Lang, D. Breen, C. Marras, M. Masellis, D. Grimes, M. Jog, B. Tan, K. Sunderland, JB. Orange, P. Mclaughlin, A. Troyer, B. Levine, D. Beaton, M. Binns, D. Munoz, R. Swartz, A. Roberts (Evanston, USA)

    Objective: We tested the assumption that speech diadochokinesis (DDK) in Parkinson’s disease (PD) parallels motor system performances by evaluating DDK changes over 12-months and testing if DDK performance predicts limb bradykinesia and rigidity UPDRS scores. Background: Studies showing that speech DDK correlates with…
  • MDS Virtual Congress 2021

    ‘Asymmetric thumb-index angle’ in PD: A new observation in an old disease

    J. Siddiqui (Columbia, USA)

    Objective: To report a novel sign on inspection in PD that is present throughout different dopaminergic states Background: Inspection is arguably one of the most…
  • MDS Virtual Congress 2021

    Wearable Devices in Movement Disorder Trials to Provide Objective Measures

    C. Martino, A. Lledó, J. Hamlet, S. Mendick (Wilmington, USA)

    Objective: To understand the validity of wearable devices in capturing objective motor and nonmotor symptoms of Parkinson’s Disease (PD) in addition to what has been…
  • MDS Virtual Congress 2020

    Compartment-specific blockade of dopamine uptake in nigrostriatal pathway reveals role for nigral dopamine function in movement frequency in open-field

    M. Salvatore, E. Kasanga, K. Lanza, S. Meadows, A. Centner, C. Bishop (Fort Worth, TX, USA)

    Objective: Inhibition of tyrosine hydroxylase activity in the substantia nigra (SN) produces a significant reduction in locomotor motor activity commensurate with decreased dopamine (DA) content…
  • MDS Virtual Congress 2020

    Smartphone-based context awareness to improve ambulatory Parkinson’s monitoring

    A. Hadley, B. Walter, A. Espay, D. Heldman (Cleveland, OH, USA)

    Objective: To determine the utility of context-awareness algorithms based on sensors in smartphones to improve ambulatory Parkinson’s disease (PD) monitoring. Background: Previous research shows that optimal motion sensor-based ambulatory PD monitoring requires multiple sensors to…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley